How to Treat Prostate Cancer With Androgen Deprivation and Minimize Cardiovascular Risk: A Therapeutic Tightrope

Vivek Narayan; Ashley E Ross; Ravi B Parikh; Anju Nohria; Alicia K Morgans

doi:10.1016/j.jaccao.2021.09.014

How to Treat Prostate Cancer With Androgen Deprivation and Minimize Cardiovascular Risk: A Therapeutic Tightrope

JACC CardioOncol. 2021 Dec 21;3(5):737-741. doi: 10.1016/j.jaccao.2021.09.014. eCollection 2021 Dec.

Authors

Vivek Narayan¹, Ashley E Ross², Ravi B Parikh¹, Anju Nohria³, Alicia K Morgans⁴

Affiliations

¹ Division of Hematology/Medical Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
² Department of Urology, Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois, USA.
³ Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
⁴ Center for Genitourinary Oncology at the Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

No abstract available

Keywords: ADT, androgen deprivation therapy; ARSI, androgen receptor signaling agent; CV, cardiovascular; CVD, cardiovascular disease; CVRF, cardiovascular risk factor; GnRH, gonadotropin-releasing hormone; RT, radiation therapy; cancer survivorship; hormonal therapy; mCSPC, metastatic castration-sensitive prostate cancer; prostate cancer; risk factor.

Publication types

Review